Caricamento...
Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis
BACKGROUND: Both the US FDA and the European Medicines Agency (EMA) have approved aripiprazole for use in adolescents for specific indications. Given the assumed favorable side-effect profile of aripiprazole, its use in children and adolescents has increased for both official and off-label indicatio...
Salvato in:
| Pubblicato in: | CNS Drugs |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4996892/ https://ncbi.nlm.nih.gov/pubmed/27395403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-016-0367-y |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|